A Study of the Experimental Remdesivir for the Treatment of COVID-19 (Coronavirus)
Logo Image
"Volunteer for research at UC Davis and contribute to discoveries that may improve health care for you, your family, and your community!"
Age: 18 years or older
Gender:
Any
Healthy Volunteers: No
Keywords: COVID-19, coronavirus
Type: Drug Study
Investigator:
Description
Viral infections are typically treated with antiviral medications as the standard of care. COVID-19 is a particularly new type of coronavirus. It is not yet fully understood if the use the antiviral medication experimental Remdesivir is indicated.

Remdesivir was shown to be active against previous types of coronaviruses referred to as SARS-CoV and MERS-CoV in animals. However, Remdesivir is not FDA approved. The manufacturer, Gilead Sciences Inc., will provide the experimental medicine to for release to patients upon approval by the FDA.

The study doctors are offering to treat COVID-19 patients with Remdesivir. This study is for patients with no standard acceptable treatment options.
This study requires

To treat your infection, you will receive treatment intravenously (via IV that you already have in place). There is a possibility you may need to have an IV placed.

You will be monitored on a regular basis for response. We will review any side effects or concerns that you may observe per instructions from the study doctors.

You will receive the treatment free of charge.

Who can participate

The study team will determine if you are eligible to take part in this study. They will review eligibility criteria with you.

Benefits and risks of participating
BENEFITS:

We cannot promise any benefits to you as a result of taking part in this research study.


RISKS:

The study team will discuss the risks associated with taking part in this research study.
Compensation
You will not be paid to take part in this research study.
Resources
Schedule
Study duration and period
We expect that the experimental treatment could last up to 10 days. This may be extended at the study doctor's discretion.
Recruitment period
From March 13, 2020
Location
UC Davis Medical Center
2315 Stockton Boulevard
Sacramento, CA 95817
Research Topic
Conditions:
  • COVID-19
  • coronavirus

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview